Wanwei Wang

506 total citations
15 papers, 249 citations indexed

About

Wanwei Wang is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wanwei Wang has authored 15 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wanwei Wang's work include Esophageal Cancer Research and Treatment (4 papers), MicroRNA in disease regulation (3 papers) and Extracellular vesicles in disease (2 papers). Wanwei Wang is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), MicroRNA in disease regulation (3 papers) and Extracellular vesicles in disease (2 papers). Wanwei Wang collaborates with scholars based in China. Wanwei Wang's co-authors include Weiguo Zhu, Guangzhou Tao, Xi‐Lei Zhou, Yu‐Suo Tong, Yaqi Song, Changhua Yu, Dongcheng He, Fu-Zhi Ji, Xiufeng Cao and Lili Yang and has published in prestigious journals such as Journal of Clinical Oncology, Oncotarget and Oral Oncology.

In The Last Decade

Wanwei Wang

14 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanwei Wang China 9 158 122 61 54 44 15 249
Shengda Cao China 12 229 1.4× 179 1.5× 31 0.5× 46 0.9× 42 1.0× 30 302
Dapeng Lei China 13 266 1.7× 199 1.6× 16 0.3× 50 0.9× 30 0.7× 33 309
Frank Ziemann Germany 8 121 0.8× 58 0.5× 35 0.6× 113 2.1× 57 1.3× 10 259
Akhila Wimalasingham United Kingdom 6 110 0.7× 42 0.3× 70 1.1× 81 1.5× 90 2.0× 10 210
Haifa Guo China 7 159 1.0× 130 1.1× 25 0.4× 71 1.3× 86 2.0× 13 291
Zhuming Lu China 8 163 1.0× 128 1.0× 20 0.3× 59 1.1× 54 1.2× 13 261
Ai-Jun Zhou China 4 170 1.1× 138 1.1× 63 1.0× 73 1.4× 56 1.3× 5 290
Zhaona Fan China 9 272 1.7× 183 1.5× 9 0.1× 99 1.8× 25 0.6× 14 362
Juan Francisco Rodríguez-Moreno Spain 9 74 0.5× 50 0.4× 59 1.0× 86 1.6× 71 1.6× 37 192
Qian Fei China 10 171 1.1× 151 1.2× 26 0.4× 48 0.9× 48 1.1× 19 264

Countries citing papers authored by Wanwei Wang

Since Specialization
Citations

This map shows the geographic impact of Wanwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanwei Wang more than expected).

Fields of papers citing papers by Wanwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanwei Wang. The network helps show where Wanwei Wang may publish in the future.

Co-authorship network of co-authors of Wanwei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wanwei Wang. A scholar is included among the top collaborators of Wanwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanwei Wang. Wanwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Xu, Yingying, et al.. (2021). Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus. International Journal of General Medicine. Volume 14. 3929–3939. 2 indexed citations
4.
Huang, Jing, et al.. (2021). CHI3L1 (Chitinase 3 Like 1) upregulation is associated with macrophage signatures in esophageal cancer. Bioengineered. 12(1). 7882–7892. 15 indexed citations
5.
Zhu, Weiguo, et al.. (2020). Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered. 11(1). 932–938. 38 indexed citations
6.
Tong, Yu‐Suo, Lili Yang, Changhua Yu, et al.. (2020). Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs. Molecular Therapy — Oncolytics. 18. 1–13. 73 indexed citations
7.
Xu, Yanjun, Weiguo Zhu, Xiao Zheng, et al.. (2018). A multi-center, randomized, prospective study evaluating the optimal radiation dose of definitive concurrent chemoradiation for inoperable esophageal squamous cell carcinoma.. Journal of Clinical Oncology. 36(15_suppl). 4013–4013. 8 indexed citations
8.
Li, Ming, et al.. (2018). Elevated Nectin-2 expression is involved in esophageal squamous cell carcinoma by promoting cell migration and invasion. Oncology Letters. 15(4). 4731–4736. 17 indexed citations
9.
Song, Yaqi, Xin-Le Kang, Gang Cao, et al.. (2016). Clinical characteristics and prognostic factors of brain central neurocytoma. Oncotarget. 7(46). 76291–76297. 9 indexed citations
10.
Song, Yaqi, Guangzhou Tao, Qing Guo, et al.. (2016). Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma. Oncotarget. 7(16). 21347–21352. 6 indexed citations
11.
12.
Wu, Qingquan, et al.. (2015). Predictive value of imaging evaluation in stage II/III esophageal carcinoma patients treated with preoperative chemoradiotherapy. Zhonghua fangshe yixue yu fanghu zazhi. 35(4). 270–273.
13.
14.
Song, Yaqi, Wanwei Wang, Guangzhou Tao, et al.. (2015). Survival benefit of radiotherapy to patients with small cell esophagus carcinoma - an analysis of Surveillance Epidemiology and End Results (SEER) data. Oncotarget. 7(13). 15474–15480. 8 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengda Cao Breakdown of academic impact, for papers by Dapeng Lei Breakdown of academic impact, for papers by Frank Ziemann Breakdown of academic impact, for papers by Akhila Wimalasingham Breakdown of academic impact, for papers by Haifa Guo Breakdown of academic impact, for papers by Zhuming Lu Breakdown of academic impact, for papers by Ai-Jun Zhou Breakdown of academic impact, for papers by Zhaona Fan Breakdown of academic impact, for papers by Juan Francisco Rodríguez-Moreno Breakdown of academic impact, for papers by Qian Fei
Rankless by CCL
2026